Solutions for Multiple Myeloma – a cancer formed by Malignant Plasma Cells: Collaboration of NYU and Technion Integrative Cancer Center | Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Feeds:: Posts; Comments

“Dangerous Thoughts on Immunotherapy” given by Polly C. Matzinger, Ph.D. Senior Investigator, Ghost Lab, Laboratory of Immunogenetics, NAID/NIH »

Solutions for Multiple Myeloma – a cancer formed by Malignant Plasma Cells: Collaboration of NYU and Technion Integrative Cancer Center

May 12, 2015 by 2012pharmaceutical

Solutions for Multiple Myeloma – a cancer formed by Malignant Plasma Cells: Collaboration of NYU and Technion Integrative Cancer Center

Reporter: Aviva Lev-Ari, PhD, RN

Technion Integrative Cancer Center – Technology Solutions for a Cure

VIEW VIDEO

https://www.youtube.com/watch?v=3Ixqmfzp6ew

Published on Apr 12, 2015

Technion Integrative Cancer Center: Technology Solutions for a Cure
The Technion is one of the few institutions in the world that brings together biology and life science expertise together with top-level physical sciences and engineering that can help win the battle against cancer, including: the Faculty of Medicine with its wonderful life sciences research, Computer Science for processing large data sets, Electrical Engineering and Physics in order to develop devices for diagnoses and imaging, and Mathematics for new algorithms.
Film made by the American Technion Society

SOURCE

https://www.youtube.com/watch?v=3Ixqmfzp6ew

Stories from Cancer Survivors in the US

http://www.cancercenter.com/community/survivors/?source=GOOGPHIL&channel=paid%2520search&c=paid%2520search%3AGoogle%3AGoogle%2520-%2520Eastern%2520Core%2520Terms%2520New%3ACancer+Survivors%253A+Multiple+Myeloma%3Amultiple+myeloma+survival+rate%3ABroad&OVMTC=Broad&site=&creative=4341909231&OVKEY=multiple%2520myeloma%2520survival%2520rate&url_id=129112683&device=c&devicemodel=&gclid=CMOEvMLSvMUCFdQRHwodBWkA2g

SOURCE

Cancer Treatment Centers of America

Posted in CANCER BIOLOGY & Innovations in Cancer Therapy | Leave a Comment

Comments RSS

Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Funding, Deals & Partnerships: BIOLOGICS & MEDICAL DEVICES; BioMed e-Series; Medicine and Life Sciences Scientific Journal – http://PharmaceuticalIntelligence.com

Solutions for Multiple Myeloma – a cancer formed by Malignant Plasma Cells: Collaboration of NYU and Technion Integrative Cancer Center

Solutions for Multiple Myeloma – a cancer formed by Malignant Plasma Cells: Collaboration of NYU and Technion Integrative Cancer Center

Technion Integrative Cancer Center – Technology Solutions for a Cure

Stories from Cancer Survivors in the US

Leave a Reply Cancel reply

Follow Blog via Email

Recent Posts

Archives

Categories

Meta

Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Funding, Deals & Partnerships: BIOLOGICS & MEDICAL DEVICES; BioMed e-Series; Medicine and Life Sciences Scientific Journal – http://PharmaceuticalIntelligence.com

Solutions for Multiple Myeloma – a cancer formed by Malignant Plasma Cells: Collaboration of NYU and Technion Integrative Cancer Center

Solutions for Multiple Myeloma – a cancer formed by Malignant Plasma Cells: Collaboration of NYU and Technion Integrative Cancer Center

Technion Integrative Cancer Center – Technology Solutions for a Cure

Stories from Cancer Survivors in the US

Share this:

Like this:

Related

Leave a Reply Cancel reply

Follow Blog via Email

Recent Posts

Archives

Categories

Meta